Strategic Partnerships Leverage past collaboration with Eurofins and FDA engagement to position as a partner for regulated diagnostic development and contract research, offering end-to-end validation workflows and compliance-ready solutions.

Automated Diagnostics Rheonix demonstrated expertise in fully automated multiplex pathogen detection; sales outreach can target customers seeking scalable, high-throughput diagnostic platforms for food safety and clinical testing in regulated environments.

Clinical Validation Network With experience in COVID-19 and respiratory panels and NYSDOH approval, there is a potential to partner on new assay development, leveraging existing regulatory pathways to accelerate market entry for similar tests.

Market Expansion Target mid-to-large biotechs and contract manufacturers seeking rapid deployment of molecular diagnostics; emphasize the Encompass platform and breadth of multiplex capabilities to differentiate from competitors.

Recovery & Renewal Given the company’s ceased operations, identify legacy customers and service opportunities such as maintenance, data integration, or transition support for existing Encompass-based systems to monetize dormant relationships.